GoldenGolden
Advanced Search
Lumira Ventures

Lumira Ventures

A venture capital and private equity firm making late stage investments in biotherapeutic, medical technology, and consumer health companies.

Lumira Ventures is a venture capital and private equity firm making late stage investments in biotherapeutic, medical technology, and consumer health companies that is headquartered in Toronto, Ontario and was founded in 1989 by Peter van der Velden. The firm also has offices in Montreal, Quebec; Vancouver, British Columbia; and Boston, Massachusetts.

Investments

Notable investments made by Lumira Ventures include: AmacaThera, Antios Therapeutics, Antiva Biosciences, Aurinia Pharmaceuticals, Bardy Diagnostics, BAROnova, Cardiac Dimensions, MAKO Surgical, Corus Pharmaceuticals, Morphotek, Celtaxsys, KAI Pharmaceuticals, Pharmasset, Alveolus, Ception Therapeutics, and Zymeworks.

Philanthropy

Companies and organizations receiving philanthropy from Lumira Ventures include: BC's Children's Hospital, SickKids Foundation, Fondation de l’Hôpital Maisonneuve-Rosemont, St. Joseph’s Healthcare Foundation, Heart and Stroke Foundation of Canada, Sunnybrook Foundation, Montreal Heart Institute Foundation, Trillium Healthcare Partners Foundation, Princess Margaret Cancer Foundation, VGH & UBC Hospital Foundation, William Osler Health System Foundation, and St. Michaels Foundation. Events and foundations supported by Lumira Ventures are the Foundation Fighting Blindness, Chrons & Colitis, Cycle for Sight, and Heart and Stroke - Big Bike.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
FinSMEs
July 27, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Josh Scott
July 26, 2021
BetaKit
Lumira has raised $276 million CAD for Fund IV, which it claims is "the largest institutional life sciences venture capital fund ever raised in Canada."
Ben Adams
July 26, 2021
FierceBiotech
Canadian life sciences fund Lumira Ventures has raised a major tranche of cash as it looks to funnel an extra $220 million into the sector.
Kyle LaHucik
June 16, 2021
FierceBiotech
Amplitude Venture Capital constructed a solid track record over the past year and a half, helping lay the groundwork for Repare Therapeutics to go public, and now the Canadian investment firm is doubling down. Amplitude closed its oversubscribed $200 million Canadian dollars ($163 million) precision medicine fund Thursday to continue investing in the Canadian life sciences sector, a space that made a big splash last year with three of the largest biotech IPOs in the country's history.
Cyrano Therapeutics
December 10, 2020
www.prnewswire.com:443
/PRNewswire/ -- Cyrano Therapeutics, a clinical stage regenerative medicine company developing a novel intranasal therapy for smell and flavor restoration, has...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.